₹613.35-4.50 (-0.73%)
04:01 PM, 2-Jan-2025₹613.10-2.55 (-0.41%)
03:49 PM, 2-Jan-2025BSE : 540222
NSE : LAURUSLABS
Sector : Health care
ISIN Code : INE947Q01028
Last Updated: 02-Jan-2025 | 09:31 PM IST
Market Cap (₹ Cr.) | 33,069 |
Traded Value (₹ Cr) | 2.26 |
Volume (Shares) | 36,807 |
Face Value (₹) | 2 |
52-Week High (₹) | 618.65 |
52-Week High Date | 02-Jan-2025 |
52-Week Low (₹) | 358.70 |
52-Week Low Date | 25-Jan-2024 |
All Time High (₹) | 723.55 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 59.60 |
All Time Low Date | 07-Aug-2019 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr.) | 33,055 |
EPS - TTM (₹) [C] | 2.43 |
P/E Ratio (X) [C] | 252.30 |
Face Value (₹) | 2 |
Latest Dividend (%) | 20.00 |
Latest Dividend Date | 06-Nov-2024 |
Dividend Yield (%) | 0.13 |
Book Value Share (₹) [C] | 76.67 |
P/B Ratio (₹) [C] | 8.00 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
SBI Multi Asset Allocation Fund (G) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund (IDCW-M) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund (IDCW-Q) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund (IDCW-A) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund - Direct (G) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund - Direct (IDCW-A) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund - Direct (IDCW-M) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund - Direct (IDCW-Q) | 30.11 | 5,25,000 | 0.43 |
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 605.70 618.25 |
Week Low/High (₹) | 556.85 618.25 |
Month Low/High (₹) | 554.10 618.25 |
Year Low/High (₹) | 360.85 618.00 |
All time Low/High (₹) | 59.60 724.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 7.41% | 7.45% | 1.87 | 1.85% |
1 Month | 6.37% | 6.29% | -0.38 | -0.36% |
3 Month | 30.88% | 30.64% | -5.13 | -6.23% |
6 Month | 40.15% | 40.06% | 0.63 | 0.27% |
1 Year | 40.76% | 40.73% | 11.20 | 11.64% |
3 Year | 13.71% | 13.77% | 37.23 | 39.38% |
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru
Registered Office: Plot No 21 Jawaharlal Nehru, Pharma City Parawada,Visakhapatnam,Andhra Pradesh-531021 Ph: 91-891-3061222
1. What's the Laurus Labs Ltd share price today?
Laurus Labs Ltd share price was Rs 613.35 at 04:01 PM IST on 2nd Jan 2025. Laurus Labs Ltd share price was down by 0.73% from the previous closing price of Rs 617.85. Laurus Labs Ltd share price trend:
2. How can I quickly analyse the performance of the Laurus Labs Ltd stock?
The performance of the Laurus Labs Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Laurus Labs Ltd?
Laurus Labs Ltd has a market capitalisation of Rs 33,069 crore.
4. What is Laurus Labs Ltd's 52-week high/low share price?
The Laurus Labs Ltd’s 52-week high share price is Rs 618.65 and 52-week low share price is Rs 358.70.
5. Is the Laurus Labs Ltd profitable?
On a consolidated basis, Laurus Labs Ltd reported a profit of Rs 42.44 crore on a total income of Rs 1,196.74 crore for the quarter ended 2024. For the year ended Sep 2024, Laurus Labs Ltd had posted a profit of Rs 17.72 crore on a total income of Rs 1,228.30 crore.
6. Which are Laurus Labs Ltd’s peers in the Health care sector?
Laurus Labs Ltd’s top 5 peers in the Health care sector are Glaxosmi. Pharma, Ajanta Pharma, Piramal Pharma, Laurus Labs, Gland Pharma, J B Chemicals &, Suven Pharma.
7. Who owns how much in Laurus Labs Ltd?
Key changes to the Laurus Labs Ltd shareholding are as follows: